The WHO has suspended the approval of tuberculosis drugs made by Mumbai-based Svizera Labs, a major supplier to developing countries, citing the company's unreliable manufacturing standards as the reason. The company's recent batches of medicine in the market should also be retested for quality, it added. Earlier, WHO had issued a warning letter to Svizera last year for the same. 